What Is Quercetin? The Senolytic in Your NMN Formula Explained

Ingredient Guide · Updated June 2026

If you look at a typical NMN article, you will read about NAD+, sirtuins, and mitochondria. What almost no NMN brand explains is the third hallmark of cellular ageing that their formula also needs to address: senescent cell accumulation. And the ingredient that addresses it: Quercetin.

Quercetin is in Nadovia's Longevity Complex at 300mg per serving. Most buyers assume it is an antioxidant add-on. It is not. It is a clinically studied senolytic — a compound that selectively clears one of the most significant drivers of age-related inflammation. This is the explanation nobody else has bothered to write.

What Senescent Cells Are and Why They Matter

Cellular senescence is a normal biological process — it is one of your body's mechanisms for preventing damaged cells from dividing and potentially becoming cancerous. A damaged or malfunctioning cell will stop dividing and enter senescence rather than replicate its problems.

The problem: senescent cells do not die quickly. They linger in tissue — sometimes for years — secreting a cocktail of inflammatory cytokines, proteases, and growth factors called the Senescence-Associated Secretory Phenotype (SASP). This inflammatory output:

• Damages adjacent healthy cells, causing a cascade of local senescence
• Drives chronic, systemic low-grade inflammation — one of the primary drivers of age-related disease
• Impairs tissue regeneration by interfering with stem cell function
• Contributes to the physical and cognitive decline associated with ageing

Young bodies clear senescent cells efficiently through immune surveillance. With age, this clearance becomes less efficient. By your 50s and 60s, a measurable proportion of cells in multiple tissue types are senescent. The accumulation correlates with arthritis, cognitive decline, metabolic dysfunction, cardiovascular disease, and impaired wound healing.

What Quercetin Is and How It Works as a Senolytic

Quercetin is a flavonoid polyphenol found in significant quantities in onions (especially red onions), capers, apples, kale, and red grapes. It is the most abundant flavonoid in the human diet.

As a senolytic, Quercetin works by inhibiting the pro-survival pathways that senescent cells depend on. Specifically, it inhibits PI3K and Bcl-2 — anti-apoptotic proteins that senescent cells upregulate to avoid programmed cell death. By blocking these survival signals, Quercetin restores the ability of senescent cells to undergo apoptosis (programmed death) while healthy cells — which rely on different survival pathways — are left largely unaffected.

This selective clearance is the key property of a true senolytic. It is not simply an antioxidant that reduces inflammation around senescent cells — it actively removes them. The difference in downstream effect is significant: removing the inflammatory source is fundamentally different from reducing the inflammation the source produces.

The Clinical Evidence

The landmark human trial: In 2019, researchers at the Mayo Clinic published the first human clinical study demonstrating that senolytic therapy (Dasatinib + Quercetin, three-day intermittent dosing) selectively reduced senescent cells in the adipose tissue of patients with diabetic kidney disease. Physical function improved. This was the first demonstration that senolytic clearance is achievable in humans.

Pulmonary fibrosis trial: A separate Mayo Clinic study found the Dasatinib + Quercetin combination improved physical function in patients with idiopathic pulmonary fibrosis — a disease characterised by accelerated cellular senescence in lung tissue.

Quercetin alone: Multiple in vitro and animal studies confirm Quercetin demonstrates senolytic activity independently of Dasatinib — though at higher doses and potentially slower timelines. Quercetin alone at 200–500mg daily is the supplementation approach most aligned with general longevity use rather than acute clinical intervention.

Anti-inflammatory and antioxidant effects: Beyond senolytic activity, Quercetin is one of the most extensively studied anti-inflammatory flavonoids in the literature — inhibiting NF-κB signalling, reducing prostaglandin synthesis, and acting as a potent antioxidant across multiple tissue types.

Why Quercetin Completes What NMN Cannot Do Alone

NMN restores NAD+ — supporting mitochondrial energy production, sirtuin activation, and DNA repair in functioning cells. NMN is exceptionally good at supporting healthy cells. It does not address dysfunctional senescent cells.

The combination of NMN + Quercetin addresses two complementary mechanisms:

• NMN: Restores energy, repair, and repair capacity in your healthy functioning cells
• Quercetin: Clears the senescent cells that are actively damaging your healthy cells and driving systemic inflammation

Without Quercetin, you are restoring energy to healthy cells while the senescent cells continue their inflammatory output. Without NMN, you are clearing senescent cells without providing the cellular energy and repair capacity needed to maintain the tissue left behind. Together, they address the two most important cellular ageing mechanisms simultaneously.

Dose and How Nadovia Uses Quercetin

Senolytic studies have used Quercetin at 500–1000mg in intermittent dosing protocols (concentrated over 2–3 days monthly). As a daily supplement in a comprehensive longevity stack, 200–500mg is the most commonly studied range for ongoing anti-inflammatory and antioxidant benefit.

Nadovia's Longevity Complex includes 300mg Quercetin per serving — within the clinically studied daily range, complementing the NMN, Resveratrol, Pterostilbene, TMG, and B12 in the same formula.

FAQ

References: Xu M et al., Nat Med (2018) — first human senolytic study; Justice JN et al., EBioMedicine (2019) — Quercetin + Dasatinib pulmonary fibrosis; Kirkland JL et al., EBioMedicine (2017) — senolytic review; pubmed.ncbi.nlm.nih.gov. Not medical advice.